Evaluating and Expanding the Opportunity for a Rare Disease Asset

Evaluating and Expanding the Opportunity for a Rare Disease Asset

Our global pharma client had an asset that would improve the standard of care in a rare but chronic condition and wanted to understand the market landscape in key markets.

The Challenge

The client needed to make a fast pipeline assessment of the opportunity and understand how best to position their asset. 

Our Approach

We used Connection, our AI-powered interview method, to reach and quickly interview over 100 rare disease specialists across the US, Europe and Gulf States.

Outcome

We helped our client understand the real-world treatment gaps that make their pipeline asset a compelling advance over today’s existing treatment protocol.

Add-on positioning resonated strongly with HCPs, which validated the client’s go-to-market strategy before launch.

In addition, our insights uncovered further growth potential for the asset, with expansion opportunities detected in earlier lines of therapy and across broader patient populations than anticipated.

Find out how to get insights fast and move forward with clarity using Connection, our AI-powered interview method.

Other Case Studies

Read More

Assessing the Market Potential for a Wearable Metabolic Tracking Device

Read More

Addressing a Competitive Threat with Speed and Clarity

Read More

Reaching Hard-to-Access Populations Through Responsible Simulation Modeling

Read More

Rapid Insight: Strengthening Competitive Understanding Through AI-Supported Analysis

Read More

Smart Foundations: Enhancing Patient-Centered Qualitative Research Through Responsible Innovation

Read More

Measuring Message Recall to Ensure Continued Campaign Impact

Tracking the performance of a revamped messaging campaign required developing a system to measure…

Read More

Comprehensive Benchmarking with Business Impact for a New Rare Disease Therapy

Launching a novel therapy for a rare disease involved building a robust system for continuous…

Read More

Simple Competitive Benchmarking with Wide-reaching Impact for an Established Brand

Benchmarking against competitors required quantitative insights that enabled performance tracking…

Read More

Establishing A Brand Tracking Research Program to Elevate Messaging for a New Brand

Establishing baseline metrics for a new biosimilar involved comprehensive quantitative research to…

Read More

Refining Positioning Through Competitive Insights

Understanding the market landscape and treatment perceptions led to refined positioning strategies…

Blogs & News

Read More
Woman at computer screen
Read More

“It’s just a chatbot with a script!” Debunking this and six other misconceptions around AI-moderated pharma market research interviews

AI-moderated interviewing emerged as an extension of the shift to online qual accelerated by COVID….

Read More
Read More

KJT Appoints Jason Solack as SVP of Operations

KJT today announces the appointment of Jason Solack as Senior Vice President of Operations. In this…

Read More
Read More

Bridging the Gap in Rare Disease Care: What Patients and Physicians Need From Each Other

In rare disease care, communication between patients and physicians is often fragmented, leading to…

Read More
Read More

A New Lens on the Rare Disease Journey

In rare and orphan diseases, the patient journey is often described as a “diagnostic odyssey.”…

Read More
Read More

KJT Announces Integration of Sparq’s Connection and Prediction Capabilities

KJT is expanding its portfolio with the integration of Sparq’s Connection and Prediction…

Read More
Global real world evidence team planning study timelines across regions
Read More

The Hidden Driver of RWE Success: Why Country Choice Determines Your Timeline

When planning a real-world evidence (RWE) study, teams naturally focus on design,…

Read More
Read More

Unlocking Participant Engagement: The Key to Meaningful Market Research

In pharmaceutical market research, one element remains consistently crucial: participant…

Read More
Read More

Navigating Successful Real-World Evidence Publications: An Interdisciplinary Journey

Publishing real-world evidence (RWE) research involves a comprehensive journey of strategic…

Read More
Read More

Go from Exam Room Conversations to Actionable Healthcare Insights

Understanding what goes on in the exam room between patients and HCPs remains a critical yet…

Read More
Read More

The AI Choice: When to Innovate and When to Proceed Thoughtfully in Healthcare Research

Artificial Intelligence is reshaping how life sciences organizations gather insights, understand…

Let’s Take Research Further. Together.